Cytomx Thera (CTMX) Stock Price, Quote & News

Company Profile

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index f...

Industry: Biotechnology

Sector: Healthcare

Phone: (650) 515-3185

Fax: (650) 351-0353

Website: www.cytomx.com

Address:

151 Oyster Point Boulevard, Suite 400, South San Francisco, United States

SCSteveAustin Jun. 16 at 9:47 PM

$CTMX. Im assuming they cashed in some of the warrants that were over 4 and 6 with adjustable Exercise prices of around 2.70-2.80..... Thats why momentum stopped as it crossed 3, in my opinion No worries, the company needs all the money it can get without doing another offering..... Plus the daily rsi was still scorching in oversold territory. Daily rsi went from 74 rsi on Thursday to 55 rsi today. This is a good sign. Still a very long hold. Im Holding at 1.58.

0 · Reply

MicahbRr Jun. 16 at 9:17 PM

$CTMX this is what I was bracing for last week. Just had my timing off. Lets get the warp drive back online! :) 🌌⛵️

1 · Reply

AKnee Jun. 16 at 8:13 PM

$CTMX bought back a good amount of my initial full position that I sold above 2.90.

1 · Reply

Turokk Jun. 16 at 8:11 PM

$CTMX

0 · Reply

LittleWhiteBall Jun. 16 at 7:18 PM

$CTMX normal dip. Was a bit overbought. Still a $3.80 gap to fill.

1 · Reply

ace_10 Jun. 16 at 7:12 PM

$CTMX anyone know why this is going down?

1 · Reply

Tom678 Jun. 16 at 5:49 PM

$CTMX patience is key here , hold for gold

1 · Reply

AITechBot Jun. 16 at 5:42 PM

$CTMX held up well! 11/2 crowd will stabilize till close. See if we cant get back to .70-.80’s

0 · Reply

GoCubsGo1124 Jun. 16 at 5:40 PM

$CTMX what’s happening here? Was there dilution?

1 · Reply

Yogi79 Jun. 16 at 5:34 PM

$CTMX market is green! Why are we bloody red today?

0 · Reply

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

May 19, 2025, 8:00 AM EDT - 4 weeks ago

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

May 13, 2025, 10:34 AM EDT - 4 weeks ago

CytomX Therapeutics: Doubling Overnight On Phase 1 Data

May 12, 2025, 2:40 PM EDT - 5 weeks ago

CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)

May 12, 2025, 11:11 AM EDT - 5 weeks ago

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

May 12, 2025, 6:50 AM EDT - 5 weeks ago

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

May 12, 2025, 6:15 AM EDT - 5 weeks ago

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)

May 12, 2025, 6:15 AM EDT - 5 weeks ago

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

May 5, 2025, 8:00 AM EDT - 6 weeks ago

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 28, 2025, 4:00 PM EDT - 7 weeks ago

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

Mar 6, 2025, 6:34 PM EST - 3 months ago

CytomX Therapeutics, Inc. (CTMX) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 4:10 PM EST - 3 months ago

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

Mar 5, 2025, 8:00 AM EST - 3 months ago

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

Feb 27, 2025, 8:00 AM EST - 3 months ago

CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Jan 6, 2025, 4:05 PM EST - 5 months ago

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

Nov 27, 2024, 8:00 AM EST - 7 months ago

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

Nov 8, 2024, 8:44 AM EST - 7 months ago

CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:10 PM EST - 7 months ago

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Sep 9, 2024, 8:00 AM EDT - 10 months ago

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

Aug 8, 2024, 4:10 PM EDT - 11 months ago

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Jun 18, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

Jun 17, 2024, 4:15 PM EDT - 1 year ago

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

May 16, 2024, 4:15 PM EDT - 1 year ago

CytomX Therapeutics Announces New Employment Inducement Grants

May 9, 2024, 9:10 AM EDT - 1 year ago

CytomX stock down 30% despite encouraging cancer study results

May 8, 2024, 4:10 PM EDT - 1 year ago

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 8, 2024, 4:10 PM EDT - 1 year ago

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

May 7, 2024, 4:15 PM EDT - 1 year ago

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

May 1, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

Apr 25, 2024, 6:33 PM EDT - 1 year ago

CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town

Apr 8, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

Apr 3, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

Mar 21, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

Mar 18, 2024, 8:00 AM EDT - 1 year ago

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

Mar 11, 2024, 6:39 PM EDT - 1 year ago

CytomX Therapeutics, Inc. (CTMX) Q4 2023 Earnings Call Transcript

Mar 11, 2024, 4:10 PM EDT - 1 year ago

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

Mar 4, 2024, 8:00 AM EST - 1 year ago

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

Feb 27, 2024, 8:00 AM EST - 1 year ago

CytomX Therapeutics to Present at Upcoming March Investor Conferences

Jan 24, 2024, 8:00 AM EST - 1 year ago

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

Jan 12, 2024, 8:00 AM EST - 1 year ago

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

Jan 4, 2024, 8:00 AM EST - 1 year ago

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

Dec 21, 2023, 8:00 AM EST - 1 year ago

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 8, 2023, 2:32 AM EST - 1 year ago

CytomX Therapeutics, Inc. (CTMX) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:15 PM EST - 1 year ago

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 1, 2023, 8:00 AM EDT - 1 year ago

CytomX Therapeutics to Present at Upcoming November Investor Conferences

Oct 31, 2023, 8:00 AM EDT - 1 year ago

CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

Oct 30, 2023, 8:00 AM EDT - 1 year ago

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

Oct 18, 2023, 4:30 PM EDT - 1 year ago

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

Sep 5, 2023, 4:05 PM EDT - 1 year ago

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Aug 10, 2023, 4:05 PM EDT - 2 years ago

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

Aug 8, 2023, 10:57 PM EDT - 2 years ago

CytomX Therapeutics, Inc. (CTMX) Q2 2023 Earnings Call Transcript

SCSteveAustin Jun. 16 at 9:47 PM

0 · Reply

MicahbRr Jun. 16 at 9:17 PM

$CTMX this is what I was bracing for last week. Just had my timing off. Lets get the warp drive back online! :) 🌌⛵️

1 · Reply

AKnee Jun. 16 at 8:13 PM

$CTMX bought back a good amount of my initial full position that I sold above 2.90.

1 · Reply

Turokk Jun. 16 at 8:11 PM

$CTMX

0 · Reply

LittleWhiteBall Jun. 16 at 7:18 PM

$CTMX normal dip. Was a bit overbought. Still a $3.80 gap to fill.

1 · Reply

ace_10 Jun. 16 at 7:12 PM

$CTMX anyone know why this is going down?

1 · Reply

Tom678 Jun. 16 at 5:49 PM

$CTMX patience is key here , hold for gold

1 · Reply

AITechBot Jun. 16 at 5:42 PM

$CTMX held up well! 11/2 crowd will stabilize till close. See if we cant get back to .70-.80’s

0 · Reply

GoCubsGo1124 Jun. 16 at 5:40 PM

$CTMX what’s happening here? Was there dilution?

1 · Reply

Yogi79 Jun. 16 at 5:34 PM

$CTMX market is green! Why are we bloody red today?

0 · Reply

CrystalballsBreaker Jun. 16 at 5:28 PM

$CTMX why is this so quiet? Multiple Executive officers buying is usually an indication of bullish sentiment in the company. I added.

1 · Reply

Tom678 Jun. 16 at 2:53 PM

$CTMX it’s a great buying opportunity at this level

0 · Reply

Turdsniffer Jun. 16 at 2:51 PM

$CTMX btfd (added)

0 · Reply

AITechBot Jun. 16 at 2:05 PM

$CTMX 3 then 2.65. Needs to hold above 2$ for the next leg up

0 · Reply

Tom678 Jun. 16 at 1:38 PM

$CTMX good dip to buy

0 · Reply

Turdsniffer Jun. 16 at 11:49 AM

$CTMX I hate when it’s up pre market 😐

0 · Reply

Damage111 Jun. 16 at 11:39 AM

$CTMX 💵💵💵

0 · Reply

BigGrinch Jun. 16 at 11:39 AM

$CTMX with 100 % premium would be ok for the moment ~6 USD

0 · Reply

Tom678 Jun. 16 at 11:30 AM

$CTMX most likely, something is happening . I’m so excited

1 · Reply

Perillo1983 Jun. 16 at 11:21 AM

$CTMX Could there be a buyout coming?? I have seen this before!!!

0 · Reply

Perillo1983 Jun. 16 at 1:21 AM

$CTMX This is a very controlled up trend someone with very deep pockets knows something that is coming real soon!!

0 · Reply

allaboutchartMan Jun. 14 at 12:58 PM

$ONDS very rare i see tickets go up after an offering, long term! Look at $PLTR $CTMX

0 · Reply

Market Cap	221.71M
Revenue (ttm)	138.10M
Net Income (ttm)	31.87M
EPS (ttm)	N/A
PE Ratio	6.23
Forward PE	N/A
Profit Margin	23.08%
Debt to Equity Ratio	0.00

Volume	2,830,300
Avg Vol	5,714,448
Day's Range	N/A - N/A
Shares Out	80.62M
Stochastic %K	15%
Beta	2.11
Analysts	Strong Sell
Price Target	$5.20